UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling

Diabetologia, 2009-11, Vol.52 (11), p.2270-2276

Knop, F. K

2009

Volltextzugriff (PDF)

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Diabetologia, 2013-05, Vol.56 (5), p.965-972

2013

Volltextzugriff (PDF)

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Diabetologia, 2009-02, Vol.52 (2), p.199-207

2009

Volltextzugriff (PDF)

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

Diabetes, obesity & metabolism, 2012-06, Vol.14 (6), p.500-510

2012

Volltextzugriff (PDF)

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor

British journal of pharmacology, 2016-03, Vol.173 (5), p.826-838

2016

Volltextzugriff (PDF)

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

British journal of pharmacology, 2016-01, Vol.173 (1), p.27-38

2016

Volltextzugriff (PDF)

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Diabetes, obesity & metabolism, 2016-03, Vol.18 (3), p.300-305

2016

Volltextzugriff (PDF)

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

Journal of internal medicine, 2016-05, Vol.279 (5), p.485-493

2016

Volltextzugriff (PDF)

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

Diabetic medicine, 2013-10, Vol.30 (10), p.1214-1218

2013

Volltextzugriff (PDF)

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Diabetes, obesity & metabolism, 2016-05, Vol.18 (5), p.444-453

2016

Volltextzugriff (PDF)

Regulation of glucagon secretion by incretins

Diabetes, obesity & metabolism, 2011-10, Vol.13 (s1), p.89-94

2011

Volltextzugriff (PDF)

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Diabetes, obesity & metabolism, 2014-11, Vol.16 (11), p.1155-1164

2014

Volltextzugriff (PDF)

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Diabetologia, 2007-04, Vol.50 (4), p.797-805

2007

Volltextzugriff (PDF)

Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'

Diabetes, obesity & metabolism, 2016-09, Vol.18 (9), p.847-854

2016

Volltextzugriff (PDF)

The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide—Regardless of Etiology and Phenotype

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4897-4903

2003

Volltextzugriff (PDF)

Glucose metabolism in patients with psoriasis

British journal of dermatology (1951), 2019-02, Vol.180 (2), p.264-271

2019

Volltextzugriff (PDF)

Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study

Diabetic medicine, 2017-02, Vol.34 (2), p.272-277

2017

Volltextzugriff (PDF)

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

Diabetes, obesity & metabolism, 2016-06, Vol.18 (6), p.571-580

2016

Volltextzugriff (PDF)

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

Diabetic medicine, 2019-07, Vol.36 (7), p.854-861

2019

Volltextzugriff (PDF)

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

The journal of clinical endocrinology and metabolism, 2010-07, Vol.95 (7), p.3309-3317

2010

Volltextzugriff (PDF)

Glucagon antagonism as a potential therapeutic target in type 2 diabetes

Diabetes, obesity & metabolism, 2011-11, Vol.13 (11), p.965-971

2011

Volltextzugriff (PDF)

Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

International Journal of Obesity, 2015-11, Vol.39 (11), p.1651-1654

2015

Volltextzugriff (PDF)

On the Action of the Restricted Weyl Group on the Set of Orbits a Minimal Parabolic Subgroup

Doklady. Mathematics, 2020, Vol.101 (1), p.25-29

2020

Volltextzugriff (PDF)

Ghrelin secretion in humans – a role for the vagus nerve?

Neurogastroenterology and motility, 2018-06, Vol.30 (6), p.e13295-n/a

2018

Volltextzugriff (PDF)

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

European journal of endocrinology, 2014-09, Vol.171 (3), p.353-362

2014

Volltextzugriff (PDF)

1 – 25 von 690

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(545)
Mit Volltextzugriff
(581)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity

N‐terminally and C‐terminally truncated forms of glucose‐dependent insulinotropic polypeptide are high‐affinity competitive antagonists of the human GIP receptor

Species‐specific action of (Pro3)GIP – a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: a systematic review and meta-analysis

Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia

Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects

Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature

Regulation of glucagon secretion by incretins

Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus

Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'

The Pathophysiology of Diabetes Involves a Defective Amplification of the Late-Phase Insulin Response to Glucose by Glucose-Dependent Insulinotropic Polypeptide—Regardless of Etiology and Phenotype

Glucose metabolism in patients with psoriasis

Use of antibiotics in childhood and risk of Type 1 diabetes: a population‐based case–control study

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion

Management of people with Type 2 diabetes shared between a specialized outpatient clinic and primary health care is noninferior to management in a specialized outpatient clinic: a randomized, noninferiority trial

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

Glucagon antagonism as a potential therapeutic target in type 2 diabetes

Transfer of liraglutide from blood to cerebrospinal fluid is minimal in patients with type 2 diabetes

On the Action of the Restricted Weyl Group on the Set of Orbits a Minimal Parabolic Subgroup

Ghrelin secretion in humans – a role for the vagus nerve?

The impact of dipeptidyl peptidase 4 inhibition on incretin effect, glucose tolerance, and gastrointestinal-mediated glucose disposal in healthy subjects

Suchergebnisse filtern